CDKN2A and glioblastoma: It might imply that rather moderate upregulation of Cdkn2a, Cyclin D, and p53 expression in GBM 101.8 relative to GBM 14-4-5 and GBM 11-9-2 could have happened due to this or some other epigenetic event, which seems treacherous and worthy of further investigation.